Approval · Notice of Compliance 1727 · 2001
ZYBAN: Notice of Compliance 1727
Issued July 19, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1727
- Date
- July 19, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Smoking cessation aid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYBAN | 02238441 | Marketed |
Medicinal ingredients
- BUPROPION HYDROCHLORIDE 150 MG per TAB